Colin Glover

Colin Glover is a Director Scientist in Early Global Development at AstraZeneca, where they have worked since 2021. Previously, Colin held various senior research positions at MedImmune from 2012 to 2017 and GlaxoSmithKline between 2008 and 2010, focusing on areas such as neuroinflammation and neuronal network dynamics. Colin also contributed to oncology early clinical projects at AstraZeneca from 2018 to 2020. They earned a BSc in Molecular & Cellular Biology from the University of Bath and a PhD in Molecular Neuroscience from the University of Bristol. Colin completed a postdoctoral fellowship at the University of Bristol from 2003 to 2006.